Biopharmaceutical company developing differentiated antibody therapeutics targeting novel cancer immunotherapy pathways including IGSF8.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricing
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
